Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders

Hyaluronic acid (HA) is a Glycosaminoglycan made of disaccharide units containing N-acetyl-D-glucosamine and glucuronic acid. Its molecular mass can reach 10 MDa and its physiological properties depend on its polymeric property, polyelectrolyte feature and viscous nature. HA is a ubiquitous compound...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 23; no. 20; p. 12174
Main Authors Djoudi, Amel, Molina-Peña, Rodolfo, Ferreira, Natalia, Ottonelli, Ilaria, Tosi, Giovanni, Garcion, Emmanuel, Boury, Frank
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 12.10.2022
MDPI
SeriesHyaluronic Acid: A Versatile Polysaccharide for Biomedical Applications 2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hyaluronic acid (HA) is a Glycosaminoglycan made of disaccharide units containing N-acetyl-D-glucosamine and glucuronic acid. Its molecular mass can reach 10 MDa and its physiological properties depend on its polymeric property, polyelectrolyte feature and viscous nature. HA is a ubiquitous compound found in almost all biological tissues and fluids. So far, HA grades are produced by biotechnology processes, while in the human organism it is a major component of the extracellular matrix (ECM) in brain tissue, synovial fluid, vitreous humor, cartilage and skin. Indeed, HA is capable of forming hydrogels, polymer crosslinked networks that are very hygroscopic. Based on these considerations, we propose an overview of HA-based scaffolds developed for brain cancer treatment, central and peripheral nervous systems, discuss their relevance and identify the most successful developed systems.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMCID: PMC9602826
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms232012174